Homology Medicines is a genetic medicines company translating proprietary gene editing and gene therapy technologies into novel treatments for patients with rare diseases. 

Biotechnology

Homology Medicines

Homology Medicines' headquarters in Bedford, MA, United States

Albert Seymour

Marta MacHado

Deborah Kinch

Mike Blum

Paul Alloway

Melissa Gelormini

Steven Gillis

Matthew Patterson

Mary Thistle

Hans-Peter Kiem

Alise Reicin

Arthur Tzianabos

The Research and Development Team at Homology Medicines focuses on advancing innovative gene editing and gene therapy solutions for rare diseases. This team collaborates across various disciplines, including molecular biology, genomics, and clinical operations, to design, develop, and validate novel treatments while ensuring rigorous quality standards throughout the research process. Their efforts aim to translate scientific discoveries into safe and effective therapies for patients.

Research and Development Team

The Leadership Team at Homology Medicines is responsible for guiding the strategic direction of the company and overseeing the development and commercialization of innovative genetic therapies. Comprising key executives from various functions, including finance, development, human resources, and legal, this team collaborates to drive mission-critical decisions, foster a culture of innovation, and ensure compliance while focusing on delivering transformative treatments for patients with rare diseases.

Leadership Team

The Quality Control and Assurance Team at Homology Medicines ensures that all genetic therapies meet rigorous safety and efficacy standards. They oversee testing and validation processes, implement quality management systems, and collaborate with other departments to maintain compliance with regulatory requirements, ultimately safeguarding the integrity of treatments for patients with rare diseases.

Quality Control and Assurance Team

The Operations Team at Homology Medicines is responsible for overseeing the efficient functioning of facilities and processes critical to the development and production of genetic therapies. This includes managing site operations, maintaining the animal care facility, and ensuring that manufacturing protocols are adhered to, all while aligning with regulatory standards to deliver innovative treatments for patients with rare diseases.

Operations Team

The Research and Development team at Homology Medicines focuses on advancing innovative gene editing and therapy solutions by spearheading the discovery and development of treatments for rare genetic diseases. This multidisciplinary team collaborates on strategic planning, operations, and optimizes manufacturing processes to ensure the successful translation of cutting-edge research into safe and effective therapies for patients in need.

Research and Development

The Finance and Accounting team at Homology Medicines is responsible for overseeing the company's financial operations, including budgeting, reporting, and compliance. They ensure accurate financial records, manage accounting processes, and support strategic financial decisions that align with the company's mission to develop innovative genetic therapies. Their expertise is crucial in maintaining fiscal health as the company advances its groundbreaking treatments for rare diseases.

Homology Medicines

Org chart

Board & advisors

Teams

Research and Development Team

Leadership Team

Quality Control and Assurance Team

Operations Team

Research and Development

Finance and Accounting

Offices

Homology Medicines

Org chart

Board & advisors

Teams

Research and Development Team

Leadership Team

Quality Control and Assurance Team

Operations Team

Research and Development

Finance and Accounting

Offices

Related companies